3rd Alpine Winter Conference on Medicinal and Synthetic Chemistry

 St. Anton, Austria    January 30-February 3, 2022

Keynote Speakers

Prof. Angela KOEHLER
MIT KOCH INSTITUTE FOR INTEGRATIVE CANCER RESEARCH, Cambridge, United States

Prof. Paul KNOCHEL
LUDWIG MAXIMILIANS UNIVERSITY, Munich, Germany
Read more

Dr Wendy YOUNG
GENENTECH, South San Francisco, United States

Invited Speakers

Prof. Ed ANDERSON
UNIVERSITY OF OXFORD, Oxford, United Kingdom

Dr Kevin BEAUMONT
ASTRAZENECA, Cambridge, United Kingdom

Studies with Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors

Dr Agustin CASIMIRO-GARCIA
PFIZER, United States
Read more

Dr Matthew CHEESEMAN
THE INSTITUTE OF CANCER RESEARCH, Sutton, United Kingdom

Innovative Strategies to Target Non-Coding RNAs with Synthetic Ligands

Dr Maria DUCA
UNIVERSITY OF CÔTE D'AZUR, Nice, France
Read more

Dr Robin FAIRHURST
NOVARTIS, Basel, Switzerland

Basic Concepts in TMDD

Mr David FAIRMAN
GSK, Cambridge, United Kingdom
Read more

Prof. Tanja GAICH
UNIVERSITY OF KONSTANZ, Konstanz, Germany

Intracellular Oligonucleotide Distribution and Protein Binding

Dr Alice GHIDINI
ASTRAZENECA, Gothenburg, Sweden
Read more

Enabling Fragment-based Drug Discovery (FBDD) with Automated Synthesis Technologies

Dr Rachel GRAINGER
ASTEX PHARMACEUTICALS, Cambridge, United Kingdom
Read more

Lessons in Transcellular Membrane Permeability Re-Learned

Dr Mike HANN
GSK MEDICINES RESEARCH CENTRE, Stevenage, United Kingdom
Read more

Molecular Chameleonicity and Cell Permeability of Drugs and PROTACs in the bRo5 Space

Prof. Jan KIHLBERG
UPPSALA UNIVERSITY, Uppsala, Sweden
Read more

Rapid Development of Robust Reactions and Multi-Step Syntheses

Prof. Alexei LAPKIN
UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom
Read more

Prof. Ang LI
SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, Shanghai, China

Dr Xiaoshen MA
MERCK & CO., INC, Boston, United States

Dr Timothy NEWHOUSE
YALE UNIVERSITY, New Haven, United States

Design and Discovery of Clinical Candidate eFT226, a First-in-Class Inhibitor of the RNA Helicase eIF4A

Dr Christian NILEWSKI
GENENTECH, South San Francisco, United States
Read more

Drugging RNA – A Structure-based Approach

Dr Jennifer PETTER
ARRAKIS THERAPEUTICS, Waltham, United States
Read more

Synthesis and Functionalization of Cyclopropane Derivatives

Dr Sophie ROUSSEAUX
UNIVERSITY OF TORONTO, Toronto, Canada
Read more

Dr Anna RUTKOWSKA-KLUTE
GSK, Germany

Dr David SARLAH
UNIVERSITY OF ILLINOIS, Urbana, United States

Dr Nicolas THOMÄ
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH, Basel, Switzerland